systemic%20lupus%20erythematosus%20(pediatric)
SYSTEMIC LUPUS ERYTHEMATOSUS (PEDIATRIC)
Systemic lupus erythematosus is a chronic, multisystem, inflammatory, autoimmune disorder characterized by formation of autoantibodies directed against self-antigens and immune-complex formation.
It can be suspected when ≥2 organ systems are involved.
It is predominantly diagnosed in females of childbearing age, rarely diagnosed before 8 years old.
Clinical presentation varies in different patients and the disease activity varies over time in a single patient. Majority of patients have arthralgia of the hand.

Systemic Lupus Erythematosus (Pediatric) References

  1. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999 Sep;42(9):1785-1796. doi: 10.1002/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#. PMID: 10513791
  2. Bertsias G, Loannidis JPA, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus: report of a task force of the EULAR standing committee for international clinical studies including therapeutics. Ann Rheum Dis. 2008 Feb;67(2):195-205. doi: 10.1136/ard.2007.070367. PMID: 17504841
  3. Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Aug 19, 2010. Ann Rheum Dis. 2010 Dec;69(12):2074-2082. http://ard.bmj.com/content/69/12/2074.full.pdf+html. PMID: 20724309
  4. Cervera R, Font J. Therapeutic perspectives in systemic lupus erythematosus. Current Rheumatol Rev. 2005 Jan;1(1):45-47
  5. Gill JM, Quisel AM, Rocca PV, et al. Diagnosis of systemic lupus erythematosus. Am Fam Physician. 2003 Dec;68(11):2179-2186. http://www.aafp.org/afp/2003/1201/p2179.pdf. PMID: 14677663
  6. Kumar A. Indian guidelines on the management of SLE. J Indian Rheumatol Assoc. 2002;10:80-96
  7. Petri M. Treatment of systemic lupus erythematosus: an update. Am Fam Physician. 1998 Jun;57(11):2753-2760. http://www.aafp.org/afp/1998/0601/p2753.html. PMID: 9636338
  8. Hahn BH, McMahon MA, Wilkinson A, et al; American College of Rheumatology. American College of Rheumatology guidelines for screening, case definition, treatment and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808. doi: 10.1002/acr.21664. PMID: 22556106
  9. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug;64(8):2677-2686. doi: 10.1002/art.34473. PMID: 22553077
  10. Gripenberg-Gahmberg M. Systemic lupus erythematosus (SLE). EBM Guidelines. Evidence-Based Medicine. Helsinki, Finland: Wiley Interscience, John Wiley & Sons; 2006 May
  11. Klein-Gitelman MS. Systemic lupus erythematosus. In: Kliegman RM, Behrman RE, Jenson HB, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders, Elsevier; 2007.
  12. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  13. Hsieh C. Belimumab for systemic lupus erythematosus. American College of Rheumatology website. http://www.rheumatology.org. Accessed 29 Aug 2013.
  14. Bartels CM. Systemic lupus erythematosus. eMedicine. http://www.emedicine.com. 2007. Accessed 22 Sep 2008.
  15. Klein-Gitelman MS. Systemic lupus erythematosus. eMedicine. http://www.emedicine.com. 2006.
  16. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis. 2014 Jun;73(6):958-967. http://ard.bmj.com/content/early/2014/04/16/annrheumdis-2013-205139.full.pdf. PMID: 24739325
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Yesterday
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 2 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Christina Lau, 6 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.